CD274 and breast cancer: To investigate the efficacy of a newly generated PD-L1–CAR against breast cancer cell lines, PD-L1–CAR T cells or NK cells were incubated with target MDA-MB-231 (PD-L1high) or MCF-7 (PD-L1low/null) cells.